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Abstract
Background:  The recent determination of the complete nucleotide sequence of several
Mycobacterium tuberculosis (MTB) genomes allows the use of comparative genomics as a tool for
dissecting the nature and consequence of genetic variability within this species. The multiple
alignment of the genomes of clinical strains (CDC1551, F11, Haarlem and C), along with the
genomes of laboratory strains (H37Rv and H37Ra), provides new insights on the mechanisms of
adaptation of this bacterium to the human host.
Findings: The genetic variation found in six M. tuberculosis strains does not involve significant
genomic rearrangements. Most of the variation results from deletion and transposition events
preferentially associated with insertion sequences and genes of the PE/PPE family but not with
genes implicated in virulence. Using a Perl-based software islandsanalyser, which creates a
representation of the genetic variation in the genome, we identified differences in the patterns of
distribution and frequency of the polymorphisms across the genome. The identification of genes
displaying strain-specific polymorphisms and the extrapolation of the number of strain-specific
polymorphisms to an unlimited number of genomes indicates that the different strains contain a
limited number of unique polymorphisms.
Conclusion: The comparison of multiple genomes demonstrates that the M. tuberculosis genome
is currently undergoing an active process of gene decay, analogous to the adaptation process of
obligate bacterial symbionts. This observation opens new perspectives into the evolution and the
understanding of the pathogenesis of this bacterium.
Background
The genome of Mycobacterium tuberculosis (MTB), consid-
ered to be mosaic in structure, has been proposed to be
the result of ancient horizontal DNA exchange and subse-
quent clonal expansion [1]. The MTB genome is highly
conserved and is considered a "closed pan-genome" due
to the bacterium's restricted niche that limits access to the
global microbial gene pool [2]. Despite the limited
genetic variation, there is a high degree of phenotypic var-
iability among MTB isolates, including differences in clin-
ical outcome and epidemiological behavior that involve
host and environmental factors, as well as bacterial deter-
minants [3,4].
The genome sequences of six MTB strains are available
and include the laboratory reference H37Rv [5] and avir-
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ulent H37Ra strains and clinical isolates. Strain CDC1551
caused an outbreak with extensive transmission of tuber-
culosis that is related to increased virulence [6]. The F11
strain represents the largest proportion of all isolates from
tuberculosis patients in the Western Cape of South Africa
[7]. The C strain is a drug-susceptible strain resistant to
reactive nitrogen intermediates that spread among intra-
venous drug users [8]. The Haarlem strain belongs to a
widely distributed genotype with reduced virulence in the
murine model [9]. Genome-wide analyses of genetic vari-
ation among different MTB strains can help to unveil char-
acteristics regarding the virulence and adaptation of this
successful human pathogen.
In this study we analyzed the variation dynamics of the
MTB genome by carrying out a multiple genome align-
ment of the six sequenced strains. The variations identi-
fied were then examined using a combinatorial approach
that allows simultaneous comparison of all strains, rather
than pair-wise comparisons of each to a reference
genome, thus providing information about unexplored
features of the MTB genome. This study gives insight into
the evolution of the MTB genome and the mechanisms of
adaptation of this pathogen to its human host.
Methods
Multiple genome alignments were carried out with the
freeware MAUVE v1.3 [10] using the genomes of MTB
strains H37Rv (NC_000962), H37Ra (NC_009525),
CDC1551 (NC_002755), F11 (NC_009565), C (NZ_AAK
R00000000) and Haarlem (NZ_AASN00000000), the lat-
ter two from the Broad Institute http://www.broad.mit.ed
u (See Additional File 1 for detailed Methods). A Perl-
based package called islandsanalyser  (Additional File 2)
was designed to analyze the distribution and frequency of
the LSPs identified in the alignment.
Results and discussion
Genome structure and genetic variation
The multiple genome alignment of the six MTB genomes
showed extensive collinearity and the absence of wide-
spread major rearrangement events. The limited number
of rearrangements identified involved mobile genetic ele-
ments located at different sites along the genome. These
variations were considered InDels, and not true rearrange-
ments, when absent from some of the genomes in the
dataset. This is exemplified by the phiRv1 phage, which
was absent in the F11 and C strains and had a location
that differed in strains H37Rv and H37Ra with respect to
strains CDC1551 and Haarlem. Differential insertions of
mobile genetic elements such as IS6110  were also
detected and, again, considered as InDels when not
present in the same location in all strains analyzed. This
analysis indicated great stability in genomic structure and
organization, characteristics that may be a consequence of
the intracellular life-style of the tubercle bacilli, which
limits the interaction with other microbial gene pools.
Genetic variation in MTB is considered to occur through
single nucleotide polymorphisms (SNPs) [11] and irre-
versible genetic events, such as large sequence polymor-
phisms (LSPs), which are believed to be the main source
of phenotypic variability [12]. To determine the extent of
genetic variation caused by LSPs, the polymorphisms
identified in the multiple alignment were classified into
different functional categories according to the genes
affected (Figure 1). LSPs from 50 bp (the smallest size
reported) to 12 kb were found to involve 120 genes. We
did not find LSPs in genes for stable RNAs or in genes pre-
viously implicated in virulence, adaptation or detoxifica-
tion. Two functional categories represented 65% of the
total genes containing LSPs: 1) mobile genetic elements
such as insertion sequences and phages and 2) the PE/PPE
family of genes that contain repetitive sequences. This is
consistent with the notion that these elements are known
to drive the generation of small genetic polymorphisms
[13]. The remaining LSPs were found in categories where
it is common to find genes with redundant functions and
suggests that MTB allows gene loss while avoiding delete-
rious effects. Finally, LSPs were detected in three genes
annotated as transcriptional regulators (Rv0823c, Rv0792c
and Rv1353c) that, although not essential for MTB sur-
vival [14], may be important in controlling gene expres-
sion under certain conditions.
The extent of LSPs present in intergenic regions had never
before been determined for various genomes. We found
that 45.8% of the total LSPs identified were present (com-
plete or partially) in intergenic regions, indicating that
variation is not targeted solely to coding sequences. This
multiple alignment also identified LSPs in more genes,
120 versus 95, than would have been identified using
microarrays to compare these same MTB strains against
the H37Rv reference genome. This difference is due to the
fact that our analysis was combinatorial and not limited
to the identification of deletions with respect to a single
reference genome. Thus this approach identified differen-
tial IS6110 integration sites, LSPs as small as 50 bp and
LSPs in intergenic regions and genes of the PE/PPE family,
which had not been investigated before [12]. These
results, in addition to the SNP and microsatellite poly-
morphisms previously reported [15], indicate that the
genetic variation within MTB is greater than previously
expected.
Distribution and frequency of polymorphisms
The observed skewed distribution of LSPs in the different
functional categories could be the result of traits intrinsic
to the MTB genome that constrain the accumulation of
polymorphisms to specific regions of the chromosome. InBMC Research Notes 2008, 1:110 http://www.biomedcentral.com/1756-0500/1/110
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this scenario, all the MTB strains should display similar
patterns of LSP distribution. We therefore developed a
tool (Additional file 2) to evaluate the presence and fre-
quency of polymorphisms using a sliding window that
identifies and represents variable regions as a continuous
string, rather than as a step-wise count, for the presence of
LSPs (as in a histogram). This avoids the over representa-
tion of small polymorphisms and the under representa-
tion of large polymorphisms that result from using
discrete window presence/absence counts. The graphical
output, which represents both LSP size and variability
among strains, showed that the polymorphisms were
spread across the entire genome and differed among
strains, indicating that they were not constrained to the
same genomic regions (Figure 2). As expected, highly var-
iable regions corresponded to IS6110 insertion sites and
the presence of the phiRv1 phage. This differential distri-
bution and frequency of polymorphisms raised the possi-
bility that there should be a limited number of
polymorphisms unique to each strain.
To test this hypothesis we determined the number of
strain-specific polymorphisms, independently of strain
order, by the sequential addition and comparison of new
MTB genomes. Strain-specific polymorphisms were sepa-
rated into the following categories: i) specific deletions
(SD), defined as a region absent in a particular strain and
present in the rest of the dataset when n-1 genomes are
compared, where n is the number of genomes compared;
and ii) specific insertions (SI), a region unique to a partic-
ular strain and absent in the rest of the dataset when n-1
genomes are compared. The results obtained for the
number of strain-specific deletions and insertions for all
combinations of comparisons in a collection length of n =
2, 3, ...6, of the six genomes in the dataset were fitted to an
exponential decay function to determine the number of
specific deletion and specific insertions when the nth
genome is included (Figures 3 and 4).
According to our hypothesis, the number of both types of
strain-specific polymorphisms should decrease as more
genomes are included. Interestingly, the value of strain-
specific polymorphisms did not tend to an asymptotic
value of zero but tended towards 7.6 ± 1.7 strain-specific
deletions and 5.1 ± 1.1 strain-specific insertions when the
nth genome is included. In addition, the variation dynam-
ics differed among strains. For example, the laboratory
strains presented fewer strain-specific polymorphisms, 1
SD and 1 SI in H37Rv and 2 SI in H37Ra, than clinical
strains isolated during outbreaks. There were 12 strain-
specific polymorphisms in CDC1551 (10 SD and 2 SI), 18
in Haarlem (12 SD and 6 SI) and 20 each in F11 (6 SD and
14 SI) and C (19 SD and 1 SI). This indicates that interac-
tion with the human host is important in driving the gen-
eration and selection of genomic changes. The tendency
observed by extrapolation of the number of genomes to
infinite indicated that as additional genomes are included
in the analysis only a small number of new strain-specific
polymorphisms would be observed. The tendency to
accumulate InDels also indicates that the MTB genome is
under an active process of gene decay reminiscent of the
Functional category classification of the LSPs found in the multiple alignments Figure 1
Functional category classification of the LSPs found in the multiple alignments. Dark green bars represent the var-
iation in each category respect to the total of LSPs. The percentages are given with respect to a total of 166 matches because 
there are genes that are classified in more than one functional category. Light green bars represent the percentage of LSPs 
found respect to the total number of genes in each category. The percentage of the intergenic region category (red bar) repre-
sents the LSPs that involved a non-coding region.
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Distribution and frequency of LSPs in strains H37Rv, H37Ra, CDC1551, F11, Haarlem and C Figure 2
Distribution and frequency of LSPs in strains H37Rv, H37Ra, CDC1551, F11, Haarlem and C. The picture depicts 
LSP sites observed for each of the six strains (MTB H37Rv, H37Ra, CDC1551, F11, Haarlem and C) with respect to the other 
strains. The frequency of the LSP can be inferred from the color scale. Background color represents invariable positions. The 
base of the square is 25,000 bp and the sizes of the LSPs are proportionately scaled.
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adaptation process of obligate symbiotic bacterial patho-
gens [16].
Genomic configuration of MTB strains
The genes involved in strain-specific deletions and inser-
tions are summarized in Tables 1 and 2, respectively.
Interestingly, we found that the avirulent laboratory strain
H37Ra lacked specific deletions in comparison with the
virulent strains, suggesting that loss of virulence in this
strain is not a consequence of gene deletion. The larger
genome of H37Ra, with respect to H37Rv, also suggests
that virulent strains might enhance their fitness by means
of gene loss. We also found that strain-specific deletions
involving the PE/PPE gene family were identified only in
clinical strains, consistent with their proposed function as
variable surface antigens and mediators of interactions
with host cells [17,18]. Other strain-specific deletions
were also found in genes associated with the immune
response. For instance, strain F11 lacked an entire gene
encoding one of the culture filtrate proteins (CFP10A)
known to mediate cellular immune responses [19]. The
three LSPs related with transcriptional regulatory proteins
correspond to strain-specific deletions of the Haarlem
(Rv0823c and Rv1353c) and CDC1551 strains (Rv0792c).
In terms of strain-specific insertions, unique insertion
sites of the IS6110 element were predominant. Strain F11,
for example, had 12 unique insertion sites for this ele-
ment, suggesting that transposition events are important
for variation in this particular genotype [20,21]. Both
types of strain-specific polymorphisms were found in
intergenic regions, with events such as insertion of trans-
posons and duplication or loss of repeated regions
between coding sequences. The identification and analy-
sis of these intergenic regions is very valuable since they
may be involved in regulation of adjacent genes or may
contain as yet unknown small regulatory RNAs [22].
Strain-specific polymorphisms may also help to explain
some of the observed phenotypic differences among MTB
strains. This study is therefore hypothesis-generating and
functional analyses of the polymorphisms found can be
carried out to understand how genetic variation affects the
Extrapolation of strain-specific deletions Figure 3
Extrapolation of strain-specific deletions. The number of specific deletions is plotted as a function of the number n of 
strains. For each n, markers are the 6!/[(n - 1)!·(6 - n)!] values obtained for the different strain combinations. The continuous 
curve represents the least-squares fit of the function Fs(n) = κs exp [-n/τs] + Ω, where κs = 186.7 ± 44.3, -1/τs = -0.83 ± 0.13 and 
Ω = 7.6 ± 1.7. The best fit obtained had a correlation of 0.997.
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outcome of infection. Our results indicate that circulating
strains harbor a higher number of strain-specific polymor-
phisms (Tables 1 and 2) and suggest that interaction with
the human host results in strain-specific genomic poly-
morphisms that may in turn determine the phenotypic
differences among circulating MTB strains. While most
deletions tend to be slightly deleterious [12], some strain-
specific polymorphisms, such as the Beijing genotype's
strain-specific deletion in the pks1/15 region [4,23], may
contribute to the pathogen's virulence or its adaptation
and the establishment of stable associations with the
human host population [24]. The tendency predicted here
regarding genetic variation of the MTB genome is based
on six strains that represent only a fraction of the global
MTB population. Thus it is necessary to further investigate
the extent of intra and inter lineage genetic variation for a
more accurate prediction of the variation dynamics within
the entire MTB population. The inclusion of a larger
number of representative strains can provide a broader
understanding of how these genetic polymorphisms con-
tribute to the adaptation of certain genotypes to human
populations.
Conclusion
The multiple alignment of six MTB genomes identified
both frequency and differential distribution patterns of
polymorphisms. This study indicated that circulating MTB
strains are under active selective pressure that leads to var-
iation by means of gene loss or inactivation and suggests
that this species in a process of gene decay. The identifica-
tion of strain-specific polymorphisms may ultimately
translate into molecular markers for strain surveillance
and predictors of outbreaks in defined human popula-
tions.
Abbreviations
MTB: Mycobacterium tuberculosis; LSP: Large sequence pol-
ymorphism; InDels: Insertions and Deletions; SNP: Single
nucleotide polymorphism; SD: Specific Deletion; SI: Spe-
cific Insertion
Extrapolation of strain-specific insertions Figure 4
Extrapolation of strain-specific insertions. The number of specific insertions is plotted as a function of the number n of 
strains. For each n, markers are the 6!/[(n - 1)!·(6 - n)!] values obtained for the different strain combinations. The continuous 
curve represents the least-squares fit of the function Fs(n) = κs exp [-n/τs] + Ω where κs = 578.35 ± 198.07, -1/τs = -1.36 ± 0.18 
and Ω = 5.1 ± 1.1. The best fit was obtained with a correlation of 0.998.
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Table 1: Genes Involved in strain-specific deletions.
Position Size Genes Involved
H37Rv
1987985 6830 MT1800 (Glycosyl transferase) – MT1801 (Molybdopterin oxidoredutase) – mmpL14 (Transmembrane transport protein)
CDC1551
206981 58 Rv0175 (Probable conserved MCE Associated membrane protein)
888687 875 Rv0792c 
(GNTR-Family transcriptional regulatory protein) – Rv0793 (Hypothetical protein) – Rv0794c (Putative oxidoreductase)
2161299 139 PPE34
2349725 58 Intergenic Region between pepE (Xaa-Pro Dipeptidase) and Rv2090 (5'-3' Exonuclease)
2373345 58 C-terminal end of the Rv2112c (Hypothetical protein)
2382265 2275 PPE37 – metH (Methionine synthase)
2701639 501 Rv2406c (Conserved hypothetical protein) – Intergenic region – Rv2407 (Ribonuclease Z)
3727960 5284 PPE54 (Possible recombination event with PE-PGRS49-50 and PPE55)
3732032 192 PPE54
3948252 640 Rv3519 (Conserved hypothetical protein)
F11
374076 61 PPE5
1509585 1101 Rv1334 (Conserved Hypothetical protein – Rv1335 (CFP10A) – cysM (cysteine synthetase)
1890753 172 Possible Promoter region of Rv1668c (Probable Macrolide ABC transport. ATP binding protein)
2381228 2645 PE22 and Intergenic region
3183106 109 Rv2859c (Hypothetical amidotransferase)
3702663 104 Intergenic region between lpdA (dihydrolipoamide dehydrogenase) and Rv3304 (Conserved hypothetical protein)
Haarlem
912152 92 Rv0823c (Possible transcriptional regulatory Protein)
965426 481 PE-PGRS15
1451173 115 Intergenic region betwwen thrB (Homoserine kinase) and thrC (Threonine synthase)
1521604 4753 Rv1353c (Probable transcriptional regulatory protein) – Rv1354c (Possible diguanylate cyclase protein) – moeY (Molibdopterin biosynthesis protein) – Rv1356c 
(Hypothetical protein)B
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2060412 643 PE-PGRS33
2365930 1774 helZ (Helicase) – Rv2102 (Conserved hypothetical protein)
2546849 6480 Rv2271 (Hypothetical protein) – Rv2272 (Probable conserved transmembrane protein) – Rv2273 (Probable conserved transmembrane protein) – Rv2274c 
(Hypothetical protein) – Rv2275 (Hypothetical protein) – cyp121 (Cytochrome P450) – Rv2277c (Probable glycerolphosphodiesterase)
2792261 170 PE-PGRS42
3117314 439 Repeat region (DR) Intergenic between Rv2813 and Rv2814
3192481 87 IS1539 Transposase contained in repeat region
4033587 616 Rv3600c (Conserved hypothetical protein) – panD (Aspartate decarboxylase precursor)
4365135 84 PPE69 and Intergenic region with PE36
C
334840 6611 PE-PGRS3-PE-PGRS4-PPE3 (partially absent in Haarlem Strain)
474110 125 Rv0401 (Probable conserved transmembrane protein)
565404 113 Intergenic region between Rv0480c (Probable amidohydrolase) and Rv0481c (Hypothetical protein)
956083 54 Intergenic region between ercc3 (Probable DNA helicase) and Rv0862c (Hypothetical protein)
1984522 109 C-terminal end wag22 (PE-PGRS)
2354142 214 PE-PGRS36
2456125 115 Intergenic region between qcrB 
(Ubiquinol cytochrome C reductase) and Rv2197c (Probable conserved transmembrane protein)
2825166 53 Rv2517c (Hypothetical protein)
2914707 115 PE-PGRS44
3113322 736 Repeat region DR Intergenic between Rv2816c and Rv2817c
3182209 54 Intergenic region between frr (ribosome releasing factor) and pyrH (Uridylate kinase)
3369008 113 PPE47
3369190 81 PPE48
3369344 62 PE29
3369422 171 PE29
3426378 83 Rv3074 (Hypothetical protein)
3911404 11522 fadD17 (Fatty-acid-CoA Synthase)-PE-PGRS53-PE-PGRS54
4009833 3486 clpC1 (Probable ATP-dependent protease) – lsr2 (Probable Iron-regulated protein) – lysS (lysyl t-RNA synthetase)
4143780 560 Rv3728 (Probable conserved two domain membrane protein – drug transporter)
Gene names are according to Tuberculist http://genolist.pasteur.fr/TubercuList/ and for genes absent in the MTB H37Rv genome the names are according to the MTB CDC1551 genome 
annotation [12]. Position indicated correspond to the site where the deletion has occurred.
Table 1: Genes Involved in strain-specific deletions. (Continued)B
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Table 2: Genes Involved in strain-specific insertions.
Position Size Genes Involved
H37Rv
3551227–3552586 1359 Intergenic region between Rv3185 (Probable transposase) and Rv3188 (Hypothetical protein)
H37Ra
13627–14986 1359 Insertion of the IS6110 element between Rv0010c 
(Probable conserved membrane protein) and Rv0011c (Hypothetical protein)
1989343–1990797 1437 Insertion of the IS6110 element on the ipl locus
CDC1551
804474–804691 217 Intergenic region between rplW (50S ribosomal protein L23) and rplB (50S ribosomal protein L2)
2341782–2341840 58 MT2144 (Hypothetical protein)
F11
934662–936021 1359 IS6110 insertion in intergenic region between hypothetical proteins TBFG_10851 and TBFG_10853
1945992–1947351 1359 IS6110 insertion in Rv1724c (Hypothetical protein)
1992354–1993713 1359 IS6110 insertion in cut1 (Probable cutinase)
1997360–1998719 1359 IS6110 insertion in intergenic region between wag22 (PE-PGRS) and Rv1760 (Hypothetical protein)
2004182–2005541 1359 IS6110 insertion in intergenic region between hypothetical proteins Rv1765c and Rv1766
2017862–2019221 1359 IS6110 insertion in cyp144 (Cytochome P450)
2270442–2271801 1359 IS6110 insertion in Rv2015c (Hypothetical protein)
2349289–2350648 1359 Intergenic region between Rv2077c (Possible conserved transmembrane protein) – Rv2078 (Hypothetical protein)
2697325–2698684 1359 IS6110 insertion in Rv2390c (Hypothetical protein)
3492136–3493495 1359 IS6110 insertion in Rv3113 (Probable phosphatase)
3564263–3565622 1359 IS6110 insertion in intergenic region between Rv3183 (Possible transcriptional regulatory protein) – TBFG_13208 (Conserved hypothetical protein)
3831596–3831772 176 Intergenic region between Rv3401 (Hypothetical protein) and Rv3402c (Hypothetical protein)
3853062–3860408 2394 TBFG_13461 (Hypothetical protein) – TBFG_13462 (Hypothetical protein) – TBFG_13463 (Hypothetical protein) – TBFG_134614 (Probable Transposase) – Intergenic region
Haarlem
1071617–1072976 1359 IS6110 insertion in Rv0963c (Conserved hypothetical protein)
1714841–1716200 1359 IS6110 insertion in mmpl12 (Transmembrane protein)
1834511–1834569 58 Rv1637c (Hypothetical protein)
1973210–1973436 226 PPE24
2606037–2607396 1359 IS6110 insertion in Rv2336 (Hypothetical protein)
4144939–4144997 58 leuA (2-isopropylmalate synthase)
C
4088473–4088705 232 Rv3680 (Probable anion transporter ATPase)
Gene names are according to Tuberculist when homologous to MTB H37Rv, if not, genes are named according to the annotation of the respective genome.BMC Research Notes 2008, 1:110 http://www.biomedcentral.com/1756-0500/1/110
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Islandanalyser package. The scripts were built using Perl 5. In order to 
execute them the module Chart::Plot (available at http://search.cpan.org/
~smorton/Chart-Plot-0.11/Plot.pm) and the module GD http://
stein.cshl.org/WWW/software/GD/ must be installed. It works on any 
operating system that supports Perl, a list of systems where Perl is available 
can be obtained at http://www.perl.org/get.html. Contents: genoma.pl, 
max.pl and Graph.pl and proper documentation.
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